Oxazolidinone Antibiotic
Pregnancy: Avoid — no human data; animal studies showed fetal toxicity
Linezolid (MRSA Osteomyelitis)
Brand names: Zyvox
Adult dose
Dose: 600 mg twice daily
Route: Oral or Intravenous (bioequivalent — oral preferred when possible)
Frequency: Twice daily
Max: 1200 mg/day
Oral bioavailability is 100% — switch to oral early; no need for prolonged IV. Duration in MRSA osteomyelitis: typically 4–6 weeks. Reserve for MRSA osteomyelitis and PJI where glycopeptides are not appropriate or failed — antimicrobial stewardship essential.
Paediatric dose
Dose: 10 mg/kg
Route: Oral or IV
Frequency: Every 8 hours (<12 years); every 12 hours (12+ years)
Max: 600 mg per dose
Paediatric MRSA osteomyelitis — restricted use; serotonin syndrome risk with concurrent SSRIs
Dose adjustments
Renal
No dose adjustment required for renal impairment; metabolites accumulate in severe CKD but not clinically significant
Hepatic
No dose adjustment for mild-moderate impairment; limited data in severe hepatic impairment
Paediatric weight-based calculator
Paediatric MRSA osteomyelitis — restricted use; serotonin syndrome risk with concurrent SSRIs
Clinical pearls
- 100% oral bioavailability: unique among antibiotics with bone penetration — allows complete OPAT or community-based treatment without IV access; bone concentrations approximately equal to serum (excellent biofilm penetration)
- Myelosuppression: FBC must be checked weekly — thrombocytopenia occurs in 2–3% and is dose/duration dependent; stop if platelets fall <100 × 10⁹/L
- Optic neuropathy and peripheral neuropathy: both are irreversible if not detected early — vision assessment and neurological examination monthly for courses >28 days; any visual change = STOP immediately
- Tyramine interaction: linezolid inhibits MAO-A and MAO-B — patients must avoid tyramine-rich foods (aged cheeses, cured/smoked meats, Marmite, red wine, tap beer, some fermented foods) to prevent hypertensive crisis
- Serotonin syndrome with SSRIs: a very common co-prescription trap in orthopaedic patients — review all medications before prescribing linezolid; SSRIs are extremely prevalent in this patient population
Contraindications
- Concurrent serotonergic drugs (SSRIs, SNRIs, MAOIs, triptans) — serotonin syndrome risk
- Uncontrolled hypertension
- Carcinoid syndrome
- Phaeochromocytoma
- Concurrent vasopressor agents (relative)
Side effects
- Myelosuppression — thrombocytopenia (most important; monitor weekly), anaemia, leucopenia
- Serotonin syndrome — with serotonergic drugs; potentially fatal
- Optic neuropathy — prolonged use (>28 days); irreversible if not detected
- Peripheral neuropathy — prolonged use
- Lactic acidosis — mitochondrial toxicity with prolonged use
- GI effects — nausea, diarrhoea
Interactions
- SSRIs (fluoxetine, sertraline, citalopram) — serotonin syndrome; avoid concurrent use; wash out SSRIs 2 weeks before if possible
- MAOIs — contraindicated; severe serotonin syndrome
- Tyramine-rich foods — linezolid is a weak MAO inhibitor; avoid aged cheese, cured meats, Marmite, red wine, tap beer — hypertensive crisis risk
- Adrenergic agents (dopamine, epinephrine) — enhanced pressor response
Monitoring
- FBC weekly (especially platelets)
- Visual acuity and colour vision monthly (>28 days use)
- Peripheral neurological assessment monthly
- Serotonin syndrome symptoms
- Blood pressure
Reference: BNFc; BNF 90; IDSA MRSA Guidelines 2011; NICE Antimicrobial Prescribing Guidelines; MHRA Linezolid Safety Update; SPC Zyvox. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Vancomycin Dosing Calculator · Drug Dosing
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Kocher Criteria for Septic Arthritis · Bone & Joint Infection
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
Pathways
- Hip Fracture Management · NICE CG124 / BOA 2020
- Distal Radius Fracture · BOA / NICE
- Ankle Fracture Management · BOA / Lauge-Hansen classification
- Metastatic Spinal Cord Compression · NICE CG75 2020
- Open Fracture Management · BOA/BAPRAS 2017
- OrthoPath: Upper Limb ED Triage · OrthoPath ED Tool — ReviseMRCEM.com